algorithm
Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test
The collaboration between Sophia and Memorial Sloan Kettering Cancer Center aims to offer new testing and analytics capabilities to clinicians and researchers.
Oxford, Sanger Institute Researchers Draw on Gene Expression Testing for Sepsis Risk Algorithm
Premium
The algorithm distinguishes between groups of patients who are at high risk of developing severe illness and those who are low risk.
The company's MiCheck Prostate blood test is intended to help clinicians determine men who may be at risk of prostate cancer.
Aiforia offers a series of cancer-specific, CE-marked models and a DIY development platform for diagnostic and clinical decision support.
Sophia Genetics Partners With MSK on Clinical Decision Support, Boundless Bio on ecDNA Detection
Sophia will provide Memorial Sloan Kettering with predictive tumor analysis technology and help startup Boundless develop new therapies and MDx methods.
Nov 28, 2021
Aug 27, 2021
Aug 24, 2021
Jul 28, 2021
Aug 24, 2020